A case report of plasma exchange in imidacloprid poisoning: A promising therapeutic approach for acute toxicity
Abstract
Imidacloprid, a neonicotinoid insecticide, is commonly used in agricultural and urban settings for pest control. However, its toxic effects on both target and nontarget organisms, including humans, have raised concerns. Imidacloprid poisoning can result in a wide range of symptoms, including neurological, gastrointestinal, and cardiovascular manifestations, and may even be fatal in severe cases. In recent years, plasma exchange has emerged as a potential therapeutic approach in cases of imidacloprid poisoning, with promising outcomes reported in a few published case reports. This article reviews the role of plasma exchange in imidacloprid poisoning, highlighting its mechanism of action, clinical indications, technical aspects, and potential benefits. The article also discusses the current evidence supporting the use of plasma exchange in imidacloprid poisoning, including relevant case reports and studies. While plasma exchange appears to be a promising adjunctive therapy in managing imidacloprid poisoning, further research and clinical experience are needed to establish its effectiveness and safety. This article emphasizes the importance of early recognition and management of imidacloprid poisoning, including considering plasma exchange as a potential treatment modality in severe cases.
Related
- Clinical Severity and Serotonin Toxicity in Antidepressant Self-Poisoning: Implications for Clinical Risk Assessment
- Platelet-Rich Plasma for Facet Joint Pain: A Promising Therapeutic Role
- Understanding ROS signaling and evolution during animal regeneration offers promising opportunities for novel therapeutic approaches
- Lamotrigine-associated SJS/TEN overlap during valproate co-therapy managed with rhTNFR-Fc and therapeutic plasma exchange : A case report
- Tumor-associated calcium signal transducer 2 expression as a promising therapeutic target in esophageal squamous cell carcinoma: a combined the Cancer Genome Atlas and an institutional cohort
BibTeX
@article{yadav2026case,
title = {{A case report of plasma exchange in imidacloprid poisoning: A promising therapeutic approach for acute toxicity}},
author = {Anshika Yadav and Gajendra Nath Gupta and Pankaj Agarwal and Akhil Sheemhar},
journal = {Asian Journal of Transfusion Science},
year = {2026},
month = jul,
doi = {10.4103/ajts.ajts_76_23},
url = {https://doi.org/10.4103/ajts.ajts_76_23},
note = {CC BY-NC-SA},
}
RIS
TY - JOUR
TI - A case report of plasma exchange in imidacloprid poisoning: A promising therapeutic approach for acute toxicity
AU - Anshika Yadav
AU - Gajendra Nath Gupta
AU - Pankaj Agarwal
AU - Akhil Sheemhar
PY - 2026
DA - 2026/07/01
JO - Asian Journal of Transfusion Science
DO - 10.4103/ajts.ajts_76_23
UR - https://doi.org/10.4103/ajts.ajts_76_23
AB - Imidacloprid, a neonicotinoid insecticide, is commonly used in agricultural and urban settings for pest control. However, its toxic effects on both target and nontarget organisms, including humans, have raised concerns. Imidacloprid poisoning can result in a wide range of symptoms, including neurological, gastrointestinal, and cardiovascular manifestations, and may even be fatal in severe cases. In recent years, plasma exchange has emerged as a potential therapeutic approach in cases of imidacloprid poisoning, with promising outcomes reported in a few published case reports. This article reviews the role of plasma exchange in imidacloprid poisoning, highlighting its mechanism of action, clinical indications, technical aspects, and potential benefits. The article also discusses the current evidence supporting the use of plasma exchange in imidacloprid poisoning, including relevant case reports and studies. While plasma exchange appears to be a promising adjunctive therapy in managing imidacloprid poisoning, further research and clinical experience are needed to establish its effectiveness and safety. This article emphasizes the importance of early recognition and management of imidacloprid poisoning, including considering plasma exchange as a potential treatment modality in severe cases.
SN - 0973-6247
SN - 1998-3565
ER -